TNFSF14 and Miyoshi myopathy: The updated “SLiM” diagnostic criteria for MM include patients with a baseline bone marrow plasma cell burden (BM PC) ≥60%, free light chain ratio (FLCr) ≥100 with involved FLC ≥ 10 mg/dL, or >1 focal lesion on MRI [1].